Status: Recruiting
Study of Amplitude-Modulated Radiofrequency Electromagnetic Fields in Metastatic Pancreatic Cancer
The objective of this research is to find out what effects (good and bad), the combination of gemcitabine and nab-paclitaxel therapy (GEM-ABR for the rest of the document), standard chemotherapy for pancreatic cancer, and the TheraBionic device has on participants' condition.
Participants needed: 46
Trial details
Phase: Phase 2Age: 18+Biological sex: AllType: InterventionalSponsor: THERABIONIC INC.Updated: Mar 25, 2025Locations: 1
Eligibility criteria
Patient must have newly diagnosed untreated biopsy proven metastatic adenocarcin... [+4]
Patients treated with any chemotherapy in metastatic setting and/or who had chem... [+12]